Enveric Biosciences(NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology…
Author: admin
12 Lifespace Communities’ Health Centers Named as U.S. News & World Report’s “2021-22 Best Nursing Homes”
A total of 12 health centers as part of Lifespace communities are being recognized as the…
CVS Health to Hold Fourth Quarter and Full Year 2021 Earnings Conference Call
CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 9, 2022,…
Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference
Insilico Medicine (“Insilico”), an end-to-end artificial intelligence (AI)-driven drug discovery company, will virtually participate in the…
Blue Shield of California Promise Health Plan Provides $520,000 Support for Maternal/Infant Health Programs in Los Angeles and San Diego
First 5 LA, an independent public agency that supports the safe and healthy development of young…
Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,…
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that it has…
Digital Diagnostics Provides New Designation to Top Executives
Digital Diagnostics recently announced the designation of Co-Founder to the company’s CEO and President/COO, John Bertrand and Seth Rainford,…
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the…
Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) announced today that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and…